You do not have permission to access this chart.
Please Sign Up or Login

About:

Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone stimulating small molecule, which is in Phase 2b clinical trial for the treatment of pediatric growth hormone deficiency. The company was founded in 2011 and is headquartered in Austin, Texas.

Sector:

Healthcare

Industry:

Biotechnology

Employees:

28

Address:

Lumos Pharma, Inc. 4200 Marathon Boulevard Suite 200 Austin TX 78756 United States

Website:

Home

Phone:

512-215-2630

Leave a comment

Your email address will not be published. Required fields are marked *